Literature DB >> 27809402

Ligation and cut as a method for bile duct division in living donor right hepatectomy.

Seong Hoon Kim1, Eung Chang Lee1, Seung Duk Lee1, Sang Jae Park1.   

Abstract

The importance of bile duct division cannot be overemphasized in living donor surgery. Ligation and cut (LC) as a method for bile duct division in living donor right hepatectomy (LDRH) has never been reported. The purpose of this study was to introduce the LC method of bile duct division in LDRH. All LDRH donors were identified through a prospectively maintained database at the authors' institution between September 2009 and March 2013, and the 2 methods, LC and cut and oversewing (CO), were compared both in terms of donor and recipient outcomes of right lobe living donor liver transplantation. In the LC method, after complete parenchymal transection, the right hepatic duct was dissected in the Glisson's sheath and ligated just at the right side of the confluence, and then the right side of the ligature was cut. The LC and CO methods were performed in 109 and 134 donors, respectively. Bile duct division time (P < 0.001) and operative time (P < 0.001) were significantly shorter in the LC group than in the CO group. With a median follow-up of 60.2 months, biliary complication rate was lower in the LC group than in the CO group (0% versus 5.2%; P = 0.01), but with no significant difference between the recipient groups. All donors made a complete recovery. In conclusion, the bile ducts of living donors can be dissected safely from the Glisson's sheath, and the LC method facilitates bile duct division and has a lower incidence of biliary complication in LDRH without compromising the recipient outcomes. Liver Transplantation 23 448-456 2017 AASLD.
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 27809402     DOI: 10.1002/lt.24670

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation.

Authors:  Seong Hoon Kim; Jangho Park; Sang Jae Park
Journal:  Ann Transl Med       Date:  2019-11

2.  Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.

Authors:  Eung Chang Lee; Seong Hoon Kim; Sang-Jae Park
Journal:  Ann Transplant       Date:  2018-10-12       Impact factor: 1.530

3.  Minimal Surgical Manpower for Living Donor Liver Transplantation.

Authors:  Seoung Hoon Kim; Jang Ho Park; Byoung Ho An
Journal:  J Clin Med       Date:  2022-07-24       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.